Pillstats
Rx only · Capsule · Oral

Balsalazide Disodium

Balsalazide Disodium

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US9 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)18747
US makers9 labelers
Packages12
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 5 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$0.118$0.236$0.355$0.473Dec 2025Apr 2026Jul 2026
$0.362
Latest avg · Jul 22, 2026
-12%
Since Dec 17, 2025
9
Active US suppliers
42%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1.5K3.0K4.4K5.9K2025 Q12025 Q22025 Q32025 Q42026 Q1
4.2K
Rx · 2026 Q1
978K
Units dispensed
-19%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Apotex Corp.unknown4SUPPLYING
PD-Rx Pharmaceuticals, Inc.unknown1SUPPLYING
Carnegie Pharmaceuticals LLCunknown1SUPPLYING
Hikma Pharmaceuticals USA Inc.unknown1SUPPLYING
Golden State Medical Supply, Inc.unknown1SUPPLYING
Zydus Lifesciences Limitedunknown1SUPPLYING
AvPAKunknown1SUPPLYING
Bryant Ranch Prepackrepackager1SUPPLYING
Zydus Pharmaceuticals USA Inc.unknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.